Skip to main content
. 2017 May 30;24(9):2632–2638. doi: 10.1245/s10434-017-5897-0

Fig. 2.

Fig. 2

Recurrence-free survival (months) for a patients who received surgical treatment of all tumor sites (N = 40) and b subgroups with (N = 11) or without (N = 29) pathological complete response after surgical treatment in the study. CR complete response